Cargando…

Biological Activities Underlying the Therapeutic Effect of Quercetin on Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a chronic autoimmune disorder stemming from unrestrained immune activation and subsequent destruction of colon tissue. Genetic susceptibility, microbiota remodeling, and environmental cues are involved in IBD pathogenesis. Up to now, there are limited treatment op...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyu, Yong-Li, Zhou, Hai-Feng, Yang, Jia, Wang, Fa-Xi, Sun, Fei, Li, Jun-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338876/ https://www.ncbi.nlm.nih.gov/pubmed/35915741 http://dx.doi.org/10.1155/2022/5665778

Ejemplares similares

Arginine metabolism regulates the pathogenesis of inflammatory bowel disease
por: Li, Jun-Yi, et al.
Publicado: (2022)

Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom?
por: Wu, Jia-Feng
Publicado: (2022)

Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease
por: Fan, Fei-Yan, et al.
Publicado: (2017)

Size-Dependent Biological Effects of Quercetin Nanocrystals
por: Liu, Qian, et al.
Publicado: (2019)

Therapeutic drug monitoring for biological medications in inflammatory bowel disease
por: Cogan, Rachel C., et al.
Publicado: (2022)

Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
por: Lu, Quan, et al.
Publicado: (2022)

Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease
por: Mao, Fei, et al.
Publicado: (2017)

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
por: Zhou, Mengjiao, et al.
Publicado: (2022)

Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review
por: Zarenezhad, Elham, et al.
Publicado: (2023)

Comparative analysis of pre- and postmenopausal endometrial cancer in 216 patients
por: Lyu, Yong-Li, et al.
Publicado: (2023)

Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease
por: Sun, Jing, et al.
Publicado: (2016)

Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
por: Kapoor, Akshay, et al.
Publicado: (2021)

Quercetin suppresses inflammatory cytokine production in rheumatoid arthritis fibroblast-like synoviocytes
por: Sun, Hai-Tao, et al.
Publicado: (2021)

Synergistic Anti-tumour Effects of Quercetin and Oncolytic Adenovirus expressing TRAIL in Human Hepatocellular Carcinoma
por: Zou, Hai, et al.
Publicado: (2018)

Plant-derived exosomal nanoparticles: potential therapeutic for inflammatory bowel disease
por: Li, De-feng, et al.
Publicado: (2023)

Plant-Derived Alkaloids: The Promising Disease-Modifying Agents for Inflammatory Bowel Disease
por: Peng, Jiao, et al.
Publicado: (2019)

Immunogenicity of biologics in inflammatory bowel disease
por: Vermeire, Séverine, et al.
Publicado: (2018)

A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
por: Vaughn, Byron P.
Publicado: (2021)

Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis
por: Lv, Ya-li, et al.
Publicado: (2017)

Different therapeutic approaches on quality of life in patients with inflammatory bowel disease
por: Xu, Junjie, et al.
Publicado: (2014)

Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases
por: Tian, Cheng-mei, et al.
Publicado: (2023)

Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease
por: Xu, Qiuyun, et al.
Publicado: (2021)

Therapeutic drug monitoring in inflammatory bowel disease treatments
por: Wang, Meng-Yao, et al.
Publicado: (2022)

Breaking the Therapeutic Ceiling: Dual Biologic or Small Molecule Therapy for Refractory Inflammatory Bowel Disease
por: Ahmed, Waseem
Publicado: (2022)

Therapeutic effect and mechanism of action of quercetin in a rat model of osteoarthritis
por: Zhang, Jun, et al.
Publicado: (2019)

Biologic targeting in the treatment of inflammatory bowel diseases
por: Bosani, Matteo, et al.
Publicado: (2009)

Biologic Concentration Testing in Inflammatory Bowel Disease
por: Vaughn, Byron P., et al.
Publicado: (2015)

Prevalence of Fatigue and Unrecognized Depression in Patients with Inflammatory Bowel Disease in Remission under Immunosuppressants and Biologicals
por: Truyens, Marie, et al.
Publicado: (2021)

Therapeutic effects of lentinan on inflammatory bowel disease and colitis‐associated cancer
por: Liu, Yanrong, et al.
Publicado: (2018)

Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes
por: Chen, Shuang, et al.
Publicado: (2016)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2020)

Emerging therapeutic options in inflammatory bowel disease
por: Yamamoto-Furusho, Jesus K, et al.
Publicado: (2021)

Quercetin as a Novel Therapeutic Approach for Lymphoma
por: Soofiyani, Saiedeh Razi, et al.
Publicado: (2021)

Nanotechnology Innovations to Enhance the Therapeutic Efficacy of Quercetin
por: Pinheiro, Rúben G. R., et al.
Publicado: (2021)

Synthetic Pathways and the Therapeutic Potential of Quercetin and Curcumin
por: Hasan, Aseel Ali, et al.
Publicado: (2022)

Mechanism of quercetin therapeutic targets for Alzheimer disease and type 2 diabetes mellitus
por: Zu, Guoxiu, et al.
Publicado: (2021)

Targeting oxidative stress attenuates trinitrobenzene sulphonic acid induced inflammatory bowel disease like symptoms in rats: Role of quercetin
por: Dodda, Dilip, et al.
Publicado: (2014)

Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases
por: Papamichael, Konstantinos, et al.
Publicado: (2023)

Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
por: Li, Mengfan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nnphh8no4l1cfccnk35dgd81db